UA115290C2 - Polymorphic forms of furazidin - Google Patents
Polymorphic forms of furazidinInfo
- Publication number
- UA115290C2 UA115290C2 UAA201611302A UAA201611302A UA115290C2 UA 115290 C2 UA115290 C2 UA 115290C2 UA A201611302 A UAA201611302 A UA A201611302A UA A201611302 A UAA201611302 A UA A201611302A UA 115290 C2 UA115290 C2 UA 115290C2
- Authority
- UA
- Ukraine
- Prior art keywords
- furazidin
- polymorphic forms
- nitrofuran
- imidazolidin
- ylidene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The invention relates to the crystalline forms of Furazidin (l-{[(1E, 2E)-3-(5-nitrofuran-2-yl)prop-2-ene-l-ylidene]amino}imidazolidin-2,4-dione) and methods of preparation thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-14-44A LV15081B (en) | 2014-05-29 | 2014-05-29 | Polymorphs of furazidine |
PCT/IB2015/053968 WO2015181741A1 (en) | 2014-05-29 | 2015-05-27 | Polymorphic forms of furazidin |
Publications (1)
Publication Number | Publication Date |
---|---|
UA115290C2 true UA115290C2 (en) | 2017-10-10 |
Family
ID=53969380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201611302A UA115290C2 (en) | 2014-05-29 | 2015-05-27 | Polymorphic forms of furazidin |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3148988A1 (en) |
EA (1) | EA201692217A1 (en) |
LV (1) | LV15081B (en) |
MA (1) | MA39860A (en) |
UA (1) | UA115290C2 (en) |
WO (1) | WO2015181741A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2990402A (en) | 1958-10-07 | 1961-06-27 | Smith Kline French Lab | Preparation of 1-aminohydantoin derivatives |
FR1489091A (en) * | 1966-05-09 | 1967-07-21 | Clin Byla Ets | New hydantoins and their preparation |
WO1997019930A1 (en) | 1995-11-27 | 1997-06-05 | Lonza Ag | Process for producing 1-aminohydantoin |
PL185120B1 (en) | 1997-03-17 | 2003-02-28 | Adamed Sp Z Oo | Method of obtaining 1-{[3-(5-nitro-2-furyl)-2-propenyliden]-amino}imidazolydin-2,4-dione |
-
2014
- 2014-05-29 LV LVP-14-44A patent/LV15081B/en unknown
-
2015
- 2015-05-27 MA MA039860A patent/MA39860A/en unknown
- 2015-05-27 UA UAA201611302A patent/UA115290C2/en unknown
- 2015-05-27 EP EP15753991.7A patent/EP3148988A1/en not_active Withdrawn
- 2015-05-27 EA EA201692217A patent/EA201692217A1/en unknown
- 2015-05-27 WO PCT/IB2015/053968 patent/WO2015181741A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
MA39860A (en) | 2015-12-03 |
WO2015181741A1 (en) | 2015-12-03 |
LV15081B (en) | 2016-11-20 |
EP3148988A1 (en) | 2017-04-05 |
LV15081A (en) | 2015-12-20 |
EA201692217A1 (en) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288104A (en) | Heterocyclic compounds, preparation methods and uses thereof | |
IL264142A (en) | Multispecific antibodies against cd40 and cd137 | |
EP3596156A4 (en) | Polyamides, and methods of producing thereof | |
EP3359889A4 (en) | Thermally insulated shipping system for pallet-sized payload, methods of making and using the same, and kit for use therein | |
EP3601216A4 (en) | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same | |
EP3104865A4 (en) | Micro-organoids, and methods of making and using the same | |
EP3325966A4 (en) | Chips, detectors, and methods of making and using the same | |
EP3119753A4 (en) | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation | |
EP3484499A4 (en) | Tgfb antibodies, methods, and uses | |
EP3703743A4 (en) | Methods of oral immunotherapy | |
EP3297641A4 (en) | Methods for the storage of whole blood, and compositions thereof | |
EP3119756A4 (en) | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation | |
EP3115361A4 (en) | Heterocyclic compounds, and preparation method and use thereof | |
PT3534743T (en) | Footwear, and methods of preparing same | |
EP3640248A4 (en) | Aminopyrimidine compound, preparation method therefor and use thereof | |
IL273896A (en) | Crystalline forms of 3-substituted 1,2,4-oxadiazole | |
EP3399996A4 (en) | Methods of administering hepcidin | |
SG11202007554TA (en) | Dioxazoline compound, preparation method therefor, and uses thereof | |
WO2014174456A3 (en) | Polymorphic forms of nilotinib hydrochloride | |
MX2020012893A (en) | Protein formulations. | |
PT3135110T (en) | 1,7-diaryl-1,6-heptadien-3,5-dion derivatives, methods of making and using the same | |
EP3337805A4 (en) | Inhibitors of the tec kinase enzyme family | |
EP3530650A4 (en) | Crystalline form of (r)-4-hydroxy-2-oxo-1-pyrrolidineacetamide, preparation method therefor and use thereof | |
EP3310358A4 (en) | Compositions and methods for the treatment of substance use disorders, addiction, and psychiatric disorders | |
SG10201908248PA (en) | Processes for preparing fluoroketolides |